1.
Trustee
; 69(4): 10-4, 1, 2016 Apr.
Article
in English
| MEDLINE
| ID: mdl-27249909
ABSTRACT
Predictive analytics can help hospitals and health networks promote wellness, improve patient care, become more efficient and reduce costs. Here's whatyou need to know.
Subject(s)
Quality Improvement , Quality of Health Care/standards , Cost Control , Efficiency, Organizational/economics , Quality Improvement/statistics & numerical data , Statistics as Topic/organization & administration
2.
Hosp Health Netw
; 90(4): 22-7, 2016 Apr.
Article
in English
| MEDLINE
| ID: mdl-27220170
3.
Genet Med
; 17(8): 597-8, 2015 Aug.
Article
in English
| MEDLINE
| ID: mdl-26240972
Subject(s)
DNA/genetics , Dogs/genetics , Wolves/genetics , Animals , Animals, Domestic/genetics , DNA/analysis , Fossils , History, Ancient
4.
J Natl Cancer Inst
; 107(7)2015 Jul.
Article
in English
| MEDLINE
| ID: mdl-26142444
Subject(s)
Biosimilar Pharmaceuticals , Commerce , Drug Approval , Drug Costs , Antineoplastic Agents/adverse effects , Biosimilar Pharmaceuticals/adverse effects , Biosimilar Pharmaceuticals/economics , Biosimilar Pharmaceuticals/standards , Clinical Trials as Topic , Drug Industry/trends , Europe , Humans , United States , United States Food and Drug Administration
5.
J Natl Cancer Inst
; 106(9)2014 Sep.
Article
in English
| MEDLINE
| ID: mdl-25214564
Subject(s)
Antigens, CD19/immunology , Antigens, Neoplasm/immunology , B-Lymphocytes , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Receptors, Antigen, T-Cell/immunology , Antibodies, Monoclonal, Humanized/pharmacology , B-Lymphocytes/immunology , Clinical Trials as Topic , Humans , Inotuzumab Ozogamicin , Lymphocyte Activation , Multicenter Studies as Topic , Neoplasm, Residual/immunology , Neoplasm, Residual/therapy , Receptors, Antigen, T-Cell/drug effects , Recombinant Fusion Proteins/pharmacology , Remission Induction , Sialic Acid Binding Ig-like Lectin 2/immunology , Stem Cell Transplantation
6.
J Natl Cancer Inst
; 106(6): dju172, 2014 Jun.
Article
in English
| MEDLINE
| ID: mdl-24907388
Subject(s)
Genetic Testing , Genomics , Neoplasms/genetics , Physician's Role , Decision Making , Genetic Counseling/ethics , Genetic Counseling/methods , Genetic Counseling/standards , Genetic Counseling/trends , Genetic Testing/ethics , Genetic Testing/methods , Genetic Testing/standards , Genetic Testing/trends , Humans , Medical Oncology/methods , Medical Oncology/standards , Medical Oncology/trends , Neoplasms/diagnosis , Neoplasms/therapy , United States
7.
Nature
; 509(7498): S2-3, 2014 May 01.
Article
in English
| MEDLINE
| ID: mdl-24784426
Subject(s)
Anti-Bacterial Agents/pharmacology , Communicable Diseases/drug therapy , Drug Approval/statistics & numerical data , Drug Resistance, Bacterial , Anti-Bacterial Agents/classification , Communicable Diseases/microbiology , Drug Resistance, Bacterial/drug effects , Europe/epidemiology , Humans , Inappropriate Prescribing/statistics & numerical data , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , United States/epidemiology , United States Food and Drug Administration/statistics & numerical data
8.
Nature
; 503(7475): S14-5, 2013 Nov 14.
Article
in English
| MEDLINE
| ID: mdl-24227001
9.
J Natl Cancer Inst
; 105(16): 1159-60, 2013 Aug 21.
Article
in English
| MEDLINE
| ID: mdl-23904505
Subject(s)
Access to Information , Antineoplastic Agents , Clinical Trials as Topic , Drug Industry/trends , Information Dissemination , Neoplasms/drug therapy , Clinical Trials as Topic/economics , Clinical Trials as Topic/standards , Clinical Trials as Topic/trends , Cost-Benefit Analysis , Data Collection/economics , Drug Industry/economics , Humans , International Cooperation , Neoplasms/therapy
10.
J Natl Cancer Inst
; 104(21): 1620-1, 2012 Nov 07.
Article
in English
| MEDLINE
| ID: mdl-23104214
Subject(s)
Biomarkers, Tumor/genetics , High-Throughput Nucleotide Sequencing , Neoplasms/diagnosis , Neoplasms/genetics , Cost-Benefit Analysis , High-Throughput Nucleotide Sequencing/economics , High-Throughput Nucleotide Sequencing/methods , High-Throughput Nucleotide Sequencing/trends , Humans , Molecular Targeted Therapy , Neoplasms/drug therapy , Sequence Analysis, DNA , Sequence Analysis, RNA
11.
J Natl Cancer Inst
; 104(15): 1115-6, 2012 Aug 08.
Article
in English
| MEDLINE
| ID: mdl-22851275
Subject(s)
Correspondence as Topic , Internet/statistics & numerical data , Medical Oncology/standards , Medical Oncology/trends , Physician-Patient Relations/ethics , Telemedicine/trends , Codes of Ethics , Developed Countries , Humans , Interprofessional Relations , Monitoring, Ambulatory/statistics & numerical data , Monitoring, Ambulatory/trends , Patient Participation , Social Media/statistics & numerical data , Societies, Medical , United States
12.
J Natl Cancer Inst
; 104(5): 347-9, 2012 Mar 07.
Article
in English
| MEDLINE
| ID: mdl-22349201
Subject(s)
Biomedical Research , Stem Cell Research , Stem Cell Transplantation/trends , Adipocytes , Animals , Biomedical Research/standards , Biomedical Research/trends , Bone Marrow Transplantation/immunology , Bone Marrow Transplantation/trends , California , Graft vs Host Reaction/immunology , Hematopoietic Stem Cell Transplantation/trends , Humans , Injections, Subcutaneous , Mesenchymal Stem Cell Transplantation/trends , Plastic Surgery Procedures/methods , Research Personnel/ethics , Research Personnel/legislation & jurisprudence , Stem Cell Research/ethics , Stem Cell Research/legislation & jurisprudence , Stem Cell Transplantation/ethics , Stem Cell Transplantation/legislation & jurisprudence , Transplantation, Autologous/immunology , Transplantation, Autologous/trends
13.
J Natl Cancer Inst
; 104(2): 88-90, 2012 Jan 18.
Article
in English
| MEDLINE
| ID: mdl-22215852
Subject(s)
Immunotherapy, Adoptive/economics , Immunotherapy, Adoptive/methods , Neoplasms/drug therapy , Neoplasms/immunology , Research Support as Topic , T-Lymphocytes/immunology , Clinical Trials as Topic/economics , Cost-Benefit Analysis , Gene Transfer Techniques , Genetic Therapy/methods , Humans , Insurance, Health , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Melanoma/drug therapy , Melanoma/immunology , Neoplasms/genetics , Quality-Adjusted Life Years , Remission Induction
14.
J Natl Cancer Inst
; 103(20): 1490-1, 2011 Oct 19.
Article
in English
| MEDLINE
| ID: mdl-21972227
Subject(s)
Antimalarials/pharmacology , Antineoplastic Agents/pharmacology , Quinacrine/pharmacology , Antimalarials/adverse effects , Antineoplastic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Clinical Trials, Phase I as Topic , Humans , Neoplasms/drug therapy , Neoplasms/metabolism , Quinacrine/adverse effects , Quinacrine/analogs & derivatives , Signal Transduction/drug effects
15.
J Natl Cancer Inst
; 103(16): 1214-5, 2011 Aug 17.
Article
in English
| MEDLINE
| ID: mdl-21813409
16.
J Natl Cancer Inst
; 103(10): 781-3, 2011 May 18.
Article
in English
| MEDLINE
| ID: mdl-21551416
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Marrow Transplantation/immunology , Bone Marrow/immunology , Cyclophosphamide/administration & dosage , Graft vs Host Disease/prevention & control , Hematologic Neoplasms/therapy , Living Donors , Myeloablative Agonists/administration & dosage , Alemtuzumab , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antibodies, Neoplasm/immunology , Antibodies, Neoplasm/therapeutic use , Antigens, CD/immunology , Antigens, CD34 , Antigens, Neoplasm/immunology , CD52 Antigen , Clinical Protocols , Drug Administration Schedule , Flow Cytometry , Glycoproteins/immunology , Graft vs Host Disease/immunology , Hematologic Neoplasms/immunology , Hematologic Neoplasms/surgery , Humans , Neoplastic Stem Cells/immunology , T-Lymphocytes/immunology , Time Factors
17.
J Natl Cancer Inst
; 103(5): 364-6, 2011 Mar 02.
Article
in English
| MEDLINE
| ID: mdl-21357594
Subject(s)
Antineoplastic Agents/administration & dosage , Colonic Neoplasms/prevention & control , Hydroxymethylglutaryl CoA Reductases/genetics , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Animals , Cholesterol, LDL/blood , Cholesterol, LDL/genetics , Colonic Neoplasms/genetics , Genetic Variation , Humans , Randomized Controlled Trials as Topic , Risk , Treatment Failure
18.
J Natl Cancer Inst
; 103(7): 532-3, 2011 Apr 06.
Article
in English
| MEDLINE
| ID: mdl-21436063
Subject(s)
Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Benzamides/therapeutic use , Breast Neoplasms/genetics , Camptothecin/analogs & derivatives , Camptothecin/therapeutic use , Chemistry, Pharmaceutical , Disease-Free Survival , Epothilones/therapeutic use , Female , Genes, BRCA1 , Humans , Irinotecan , Parity , Receptor, ErbB-2/metabolism , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Risk Factors , Treatment Outcome , Tubulin Modulators/therapeutic use
19.
J Natl Cancer Inst
; 103(1): 11-2, 2011 Jan 05.
Article
in English
| MEDLINE
| ID: mdl-21169537
Subject(s)
Exercise , Integrative Medicine , Medical Oncology/methods , Meditation , Neoplasms/drug therapy , Neoplasms/psychology , Yoga , Acupuncture , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Aromatase Inhibitors/administration & dosage , Aromatase Inhibitors/adverse effects , Arthralgia/chemically induced , Arthralgia/therapy , Cancer Care Facilities/organization & administration , Evidence-Based Medicine , Fatigue/etiology , Fatigue/therapy , Hot Flashes/chemically induced , Hot Flashes/therapy , Humans , Medication Adherence , Neoplasms/complications , Neoplasms/prevention & control , Patient Care Team , Randomized Controlled Trials as Topic , Sleep Wake Disorders/etiology , Sleep Wake Disorders/therapy , Treatment Outcome , United States
20.
J Natl Cancer Inst
; 102(20): 1531-3, 2010 Oct 20.
Article
in English
| MEDLINE
| ID: mdl-20935264
